eISSN: 2299-0054
ISSN: 1895-4588
Videosurgery and Other Miniinvasive Techniques
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Share:
Send email
Share:
Review paper

Femoro-popliteal endovascular interventions

Azat Chinaliyev
1, 2
,
Samat Saparbayev
3
,
Bazylbek Zhakiyev
1
,
Gulinur Chinaliyeva
2
,
Didar Khassenov
2
,
Irlan Sagandykov
2
,
Ibrahim A. Abdelazim
4
,
Ainur Donayeva
5
,
Ainur Amanzholkyzy
5
,
Batyrbek Alibekov
6
,
Luis Arias
7
,
Nazgul Dzhantemirova
8
,
Zhenisbek Baubekov
9
,
Bibigul Karimsakova
5

  1. Department of Surgical Diseases No 2, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
  2. Department of Interventional Radiology, National Research Oncology Center, Astana, Kazakhstan
  3. Medical Director for Scientific and Clinical Work at Al-Jami, Astana, Kazakhstan
  4. Department of Obstetrics and Gynecology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
  5. Department of Normal Physiology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
  6. Department of Interventional Surgery at City Hospital No 1, Shymkent, Kazakhstan
  7. Scientific Institute of Higher Education, Santa Cruz De La Sierra, Mexico
  8. Department of Oncology, Astana Medical University, Astana, Kazakhstan
  9. Department of Pediatric Surgery, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
Videosurgery Miniinv
DOI: https://doi.org/10.5114/wiitm.2024.139548
Online publish date: 2024/05/10
Article file
- Femoro-popliteal.pdf  [0.11 MB]
Get citation
 
PlumX metrics:
 
1. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res 2015; 116: 1509-26.
2. Hiatt WR, Goldstone J, Smith SC Jr, et al.; American Heart Association Writing Group 1. Atherosclerotic Peripheral Vascular Disease Symposium II: nomenclature for vascular diseases. Circulation 2008; 118: 2826-9.
3. Rose GA. The diagnosis of ischemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962; 27: 645-58.
4. Criqui MH, Denenberg JO, Bird CE, et al. The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing. Vasc Med 1996; 1: 65-71.
5. Kansal A, Long CA, Patel MR, Jones WS. Endovascular treatment of femoro-popliteal lesions. Clin Cardiol 2019; 42: 175-83.
6. Diamantopoulos A, Katsanos K. Treating femoropopliteal disease: established and emerging technologies. Semin Intervent Radiol 2014; 31: 345-52.
7. Kasapis C, Gurm HS. Current approach to the diagnosis and treatment of femoral-popliteal arterial disease. A systematic review. Curr Cardiol Rev 2009; 5: 296-311.
8. Schillinger M, Minar E. Claudication: treatment options for femoropopliteal disease. Prog Cardiovasc Dis 2011; 54: 41-6.
9. Natarajan B, Patel P, Mukherjee A. Acute lower limb ischemia-etiology, pathology, and management. Int J Angiol 2020; 29: 168-74.
10. Rowe VL, Lee W, Weaver FA, Etzioni D. Patterns of treatment for peripheral arterial disease in the United States: 1996-2005. J Vasc Surg 2009; 49: 910-7.
11. Kudagi VS, White CJ. Endovascular stents: a review of their use in peripheral arterial disease. Am J Cardiovasc Drugs 2013; 13: 199-212.
12. Jones WS, Mi X, Qualls LG, et al. Trends in settings for peripheral vascular intervention and the effect of changes in the outpatient prospective payment system. J Am Coll Cardiol 2015; 65: 920-7.
13. Miralles M, Candela E, Blanes E, Ribé L. Reverse retrograde approach: an alternative method for ipsilateral access to the superficial femoral Artery. EJVES Short Rep 2016; 30: 7-9.
14. Meijers TA, Aminian A, van Wely M, et al. Randomized comparison between radial and femoral large-bore access for complex percutaneous coronary intervention. JACC Cardiovasc Interv 2021; 14: 1293-303.
15. Hirsch AT, Haskal ZJ, Hertzer NR, et al.; American Association for Vascular Surgery/Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)--summary of recommendations. J Vasc Interv Radiol 2006; 17: 383-97.
16. Jones WS, Schmit KM, Vemulapalli S, et al. Treatment Strategies for Patients with Peripheral Artery Disease [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 May. Report No.: 13-EHC090-EF.
17. Barton M, Grüntzig J, Husmann M, Rösch J. Balloon angioplasty – the legacy of Andreas Grüntzig, M.D. (1939-1985). Front Cardiovasc Med 2014; 1: 15.
18. Katsanos K, Spiliopoulos S, Reppas L, Karnabatidis D. Debulking atherectomy in the peripheral arteries: is there a role and what is the evidence? Cardiovasc Intervent Radiol 2017; 40: 964-77.
19. Jongsma H, Bekken J, Ayez N, et al. Angioplasty versus stenting for iliac artery lesions. Cochrane Database Syst Rev 2020; 12: CD007561.
20. Laird JR, Schneider PA, Tepe G, et al.; IN.PACT SFA Trial Investigators. Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA. J Am Coll Cardiol 2015; 66: 2329-38.
21. Scheinert D, Duda S, Zeller T, et al. The LEVANT-I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. JACC Cardiovasc Interv 2014; 7: 10-9.
22. Krishnan P, Faries P, Niazi K, et al. Stellarex drug-coated balloon for treatment of femoropopliteal disease: twelve-month outcomes from the randomized ILLUMENATE pivotal and pharmacokinetic Studies. Circulation 2017; 136: 1102-13.
23. Tepe G, Schnorr B, Albrecht T, et al. Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial. JACC Cardiovasc Interv 2015; 8: 102-8.
24. Werk M, Albrecht T, Meyer DR, et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv 2012; 5: 831-40.
25. Rosenfield K, Jaff MR, White CJ, et al.; LEVANT-II Investigators. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med 2015; 373: 145-53.
26. Scheinert D, Schulte KL, Zeller T, et al. Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial. J Endovasc Ther 2015; 22: 14-21.
27. Jia X, Zhang J, Zhuang B, et al. Acotec drug-coated balloon catheter: randomized, multicenter, controlled clinical study in femoropopliteal arteries: evidence from the AcoArt-I trial. JACC Cardiovasc Interv 2016; 9: 1941-9.
28. Torrealba JI, Vargas JF, Mariné LA, et al. Manejo endovascular de la isquemia crítica distal: análisis de una serie contemporánea [Endovascular management of chronic limb ischemia. Experience in 48 procedures]. Rev Med Chil 2020; 148: 1734-41.
29. Scheller B. Opportunities and limitations of drug-coated balloons in interventional therapies. Herz 2011; 36: 232-9.
30. Marzlin N, Jan MF, Kostopoulos L, et al. Peripheral artery disease intervention: drug-coated balloon vs drug-eluting stent, a long-term comparison. J Interv Cardiol 2022; 2022: 5175607.
31. Herten M, Stahlhoff S, Imm B, et al. Medikamentenbeschichtete Ballonkatheter in der PAVK Behandlung. Entwicklung der Methode und aktuelle Studienlage [Drug-coated balloons in the treatment of peripheral artery disease (PAD). History and current level of evidence]. Radiologe 2016; 56: 240-53.
32. Krankenberg H, Schlüter M, Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 2007; 116: 285-92.
33. Schillinger M, Sabeti S, Dick P, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007; 115: 2745-9.
34. Laird JR, Katzen BT, Scheinert D, et al.; RESILIENT Investigators. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010; 3: 267-76.
35. Saxon RR, Dake MD, Volgelzang RL, et al. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 2008; 19: 823-32.
36. Geraghty PJ, Mewissen MW, Jaff MR, Ansel GM; VIBRANT Investigators. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease. J Vasc Surg 2013; 58: 386-95.e4.
37. Lammer J, Zeller T, Hausegger KA, et al. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease). J Am Coll Cardiol 2013; 62: 1320-7.
38. Dake MD, Ansel GM, Jaff MR, et al.; Zilver PTX Investigators. Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the zilver-PTX randomized trial. Circulation 2016; 133: 1472-83.
39. Shammas NW, Coiner D, Shammas GA, et al. Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. J Vasc Interv Radiol 2011; 22: 1223-8.
40. Zeller T, Langhoff R, Rocha-Singh KJ, et al.; DEFINITIVE AR Investigators. Directional atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR study. Circ Cardiovasc Interv 2017; 10: e004848.
41. Akkus NI, Abdulbaki A, Jimenez E, Tandon N. Atherectomy devices: technology update. Med Devices (Auckl) 2014; 8: 1-10.
42. Latacz P, Simka M, Brzegowy P, et al. Mechanical rotational thrombectomy with Rotarex system augmented with drug-eluting balloon angioplasty vs. stenting for the treatment of acute thrombotic and critical limb ischaemia in the femoropopliteal segment. Videosurgery Miniinv 2019; 14: 311-9.
43. Li L, Tong Z, Cui S, Guo L. Debulking plus drug-coated balloon angioplasty versus drug-coated balloon angioplasty alone for femoropopliteal Tosaka III in-stent restenosis lesions. Videosurgery Miniinv 2023; 18: 166-72.
44. Dattilo R, Himmelstein SI, Cuff RF. The COMPLIANCE 360° Trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. J Invasive Cardiol 2014; 26: 355-60.
45. Dippel EJ, Makam P, Kovach R, et al.; EXCITE-ISR Investigators. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE-ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of Femoropopliteal In-Stent Restenosis). JACC Cardiovasc Interv 2015; 8: 92-101.
46. Jaff MR, Nelson T, Ferko N, et al. Endovascular interventions for femoropopliteal peripheral artery disease: a network meta-analysis of current technologies. J Vasc Interv Radiol 2017; 28: 1617-27.e1.
47. Patel MR, Conte MS, Cutlip DE, et al. Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol 2015; 65: 931-41.
48. Conte MS, Pomposelli FB. Society for Vascular Surgery Practice guidelines for atherosclerotic occlusive disease of the lower extremities management of asymptomatic disease and claudication. Introduction. J Vasc Surg 2015; 61 (3 Suppl): 1S.
49. Head-to-Head Trial Compares Low- to Higher-Dose Drug-Coated Balloons at a Critical Time. https://pubmed.ncbi.nlm.nih.gov/34016410/ (Accessed April 10, 2024).
50. Surmodics’ SurVeil DCB to Treat Femoropopliteal Artery Disease Evaluated at 24 Months in TRANSCEND Study. https://evtoday.com/news/surmodics-surveil-dcb-to-treat-femoropopliteal-artery-disease-evaluated-at-24-months-in-transcend-study (Accessed April 10, 2024).
51. Shockwave Medical’s IVL Compared to PTA in DISRUPT PAD-III at 2 Years. https://shockwavemedical.com/wp-content/uploads/2019/04/Disrupt-PAD-III-OS_Holden_Cx-2019.pdf (Accessed April 10, 2024).
52. Jongsma H, van Mierlo-van den Broek P, Imani F, van den Heuvel D, de Vries JPM, Fioole B. Randomized comparison of femoropopliteal artery drug-eluting balloons and drug-eluting stents (FOREST trial): Study protocol for a randomized controlled trial. J Vasc Surg 2017; 66: 1293-8.
Copyright: © 2024 Fundacja Videochirurgii This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.